Morning Versus Afternoon Aerobic Exercise in Type 1 Diabetes
Launched by UNIVERSITY OF AARHUS · Nov 2, 2023
Trial Information
Current as of November 10, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how the time of day affects exercise for people with type 1 diabetes. Researchers want to find out if exercising in the morning instead of the afternoon requires less carbohydrate intake to keep blood sugar levels stable. They will do this by having 12 participants with type 1 diabetes exercise at a moderate intensity for one hour in the morning and again in the afternoon. The study will monitor their blood sugar levels closely during both sessions to see how their bodies respond and how much glucose they need to maintain healthy levels.
To be eligible for this trial, participants must be between 18 and 65 years old, have been diagnosed with type 1 diabetes for over two years, and be physically active. Participants should either use multiple daily insulin injections or a continuous insulin pump. However, those with heart conditions or severe complications from diabetes will not be able to take part. If you join the study, you can expect to have your blood sugar monitored frequently during exercise and to provide some blood samples for testing. This research could help improve exercise recommendations for people with type 1 diabetes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age 18-65
- • male/female
- • \>2 years of type 1diabetes duration
- • multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII)
- • physically active
- Exclusion Criteria:
- • heart conditions
- • unawareness
- • severe complications to diabetes
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported